Printer Friendly
The Free Library
14,800,529 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

PhotoMedex to Present at the RBC Capital Markets Healthcare Conference.


MONTGOMERYVILLE, Pa. -- PhotoMedex, Inc. (Nasdaq:PHMD) announced today that it is scheduled to present at the RBC Capital Markets RBC Capital Markets is the corporate and investment banking division of Royal Bank of Canada ("RBC"). Broker dealers
Depending on the jurisdiction, the division uses different broker dealer subsidiaries of RBC:
  • Canada: RBC Dominion Securities Inc
 Healthcare Conference, being held December 13 - 14, 2006 at the Westin New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 at Times Square Hotel in New York City New York City: see New York, city.
New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S.
. Jeff O'Donnell and Dennis McGrath will be panel participants on the Clear Skin, Fat Wallets: Aesthetic Medicine panel to be held on Wednesday, December 13, 2006 at 11:00 am.

A live webcast of the panel discussion will be available by going to www.photomedex.com and clicking on the link to Investor Relations Investor relations

The process by which the corporation communicates with its investors.
. An archived replay will be available for a period of 30 days.

About PhotoMedex

PhotoMedex is engaged in the development of proprietary excimer laser A gas laser in which a very short electrical pulse excites a mixture containing a halogen such as fluorine and a rare gas such as argon or krypton. It produces a brief, intense pulse of ultraviolet light.  and fiber optic systems and techniques directed toward dermatological applications, with FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 510(k) clearances to market the XTRAC([R]) laser system for the treatment of psoriasis, vitiligo vitiligo
 or leukoderma

Skin disorder manifested by smooth, white spots on various parts of the body. Though the pigment-making cells of the skin, or melanocytes, are structurally intact, they have lost the ability to synthesize the pigment.
, atopic dermatitis Atopic Dermatitis Definition

Eczema is a general term used to describe a variety of conditions that cause an itchy, inflamed skin rash. Atopic dermatitis, a form of eczema, is a non-contagious disorder characterized by chronically inflamed skin and
 and leukoderma leukoderma /leu·ko·der·ma/ (-der´mah) an acquired condition with localized loss of pigmentation of the skin.

leukoderma acquisi´tum centri´fugum  halo nevus.
. In addition, the Company provides contract medical procedures to hospitals, surgi-centers and doctors' offices, offering a wide range of products and services across multiple specialty areas, including dermatology, urology, gynecology, orthopedics, and other surgical specialties. The Company is a leader in the development, manufacturing and marketing of medical laser products and services. In addition, as a result of the merger with ProCyte, PhotoMedex now develops and markets products based on its patented, clinically proven Copper Peptide technology for skin health, hair care and wound care. PhotoMedex sells directly to dermatologists, plastic and cosmetic surgeons, spas and salons and through licenses with strategic partners into the consumer market, including a long-term worldwide license agreement with Neutrogena([R]), a Johnson & Johnson company. ProCyte brands include Neova([R]), Ti-Silc([R]), VitalCopper([R]), Simple Solutions([R]) and AquaSante([R]).

SAFE HARBOR STATEMENT

Some paragraphs of this press release, particularly those describing PhotoMedex' strategies, contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1993, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. While PhotoMedex is working to achieve those goals and strategies, actual results could differ materially from those projected in the forward-looking statements as a result of a number of factors, including difficulties in marketing its products and services, need for capital, competition from other companies and other factors, any of which could have an adverse effect on the business plans of PhotoMedex, its reputation in the industry or its expected financial return from operations. Factors such as these could have an adverse effect on PhotoMedex' results of operations. In light of significant uncertainties inherent in forward-looking statements included herein, the inclusion of such statements should not be regarded as a representation by PhotoMedex and its subsidiaries that they will achieve such forward-looking statements.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Dec 7, 2006
Words:451
Previous Article:Morgan Stanley Schedules Quarterly Investor Conference Call.
Next Article:Amend: Fitch Upgrades American Capital Strategies IDR to 'BBB'; Outlook Stable.
Topics:



Related Articles
PhotoMedex to Present At American Electronics Association Financial Conference November 7-8, 2000.
[2] PhotoMedex to Present At American Electronics Association Financial Conference November 7-8, 2000.
PhotoMedex Announces That Cigna Healthcare Will Reimburse Costs of The XTRAC Laser Treatments for Mild to Moderate Psoriasis.
PhotoMedex, Inc. to Participate in CIBC World Markets Annual Health Care Conference in New York.
PhotoMedex Agrees to Acquire Surgical Laser Technologies.
PhotoMedex to Hold Third Quarter 2005 Conference Call.
Ionatron to Present at the RBC Capital Markets North American Technology Conference on August 10, 2006.
PhotoMedex Launches New Corporate Website.
PhotoMedex to Present at the Roth Capital Partners 19th Annual OC Conference.
PhotoMedex Appoints Stephen P. Connelly to the Board of Directors and R. Rox Anderson, M.D., as Chief Medical Advisor.

Terms of use | Copyright © 2010 Farlex, Inc. | Feedback | For webmasters | Submit articles